Patients and methods
The trials were carried out on 142 pregnant women and 115 gynaecological patients attending the antenatal and gynaecological clinics at the Princess Tsahai Memorial Hospital, and the Lideta Maternal and Child Health Centre, Addis Ababa. The schemes of treatment with pessaries of nitrimidazine, nystatin, and tetracycline and 250 mg. tablets of nitrimidazine are shown in Table I . Once it became apparent that a course of treatment was not achieving a satisfactory cure rate, that particular trial was abandoned. Diagnosis was made by immersing a cotton-wool swab in the secretion in the posterior vaginal fomix and transferring it to a test tube containing about 1 ml. normal saline. A suspension of this discharge was C  4  32  16  1  39  14  D  19  45  21  3  56  32  E  10  37  9  2  53  5 Vaginal discharge was the commonest symptom in all groups, followed by vulval irritation, dysuria, and dyspareunia in that order. The amount of discharge was assessed objectively and the groups were similar in this respect. There was very little correlation between the number of trichomonads, the amount of discharge, and the appearance of the vaginal epithelium.
The follow-up procedure aimed at re-examining each patient within 1 week of completing treatment by the same methods as described for the initial examination. Patients were asked to attend for further follow-up tests for a period of 12 weeks after the completion of treatment.
Results
There were a total of 24 defaulters spread fairly evenly over the five groups (Table III) (Tables III, IV, V) . Five cases with very abundant trichomonads were in hospital at the time of treatment with 2 g. nitrimidazine, and the disappearance of active trichomonads in these cases was dramatic-none were visible 12 hours later. C. albicans was seen at the initial examination in 18 cases; after treatment of the trichomonas infection, it was found in 46 cases (Table IV) . The candidiasis was not treated unless it appeared to be producing symptoms, and this only arose when the patients were receiving oral nitrimidazine.
Gram-negative intracellular diplococci were seen on only four occasions but Gram-negative extracellular diplococci were identified in 108 cases. It is likely that if culture and fermentation tests had been available a considerable number of cases of gonorrhoea would have been found.
The 142 pregnant women were treated at periods of gestation varying from 10 weeks to term (Table VI) . Fifty pregnancies have so far been followed up to completion. One patient, an unmarried deaf mute, aborted 2 weeks after taking eight nitrimidazine tablets orally at 13 weeks gestation. One primigravid patient had a fresh stillbirth 1 month after oral nitrimidazine, after a breech delivery. In the case of the missed abortion and the intrauterine death the pregnancy was already doomed before treatment was given. The remaining 46 full-term infants were all examined clinically between birth and the age of 3 months and no abnormality was found.
The incidence of side-effects appears to be rather high (Table VII, overleaf). This could be because patients were asked direct questions concerning each likely complication. Two patients discontinued vaginal treatment because of a sensation of severe burning in the vagina. Those who vomited after the oral treatment were either re-treated successfully or were judged to have vomited sufficiently long after the administration of the drug for most of it to have been absorbed.
Discussion
The mute testimony of hundreds of discarded methods of treatment (Trussell, 1947 ) is evidence of the difficulties which have arisen in vaginal treatment of unusually high but in spite of lack of cultures is likely to be correct, as the majority of patients had more than one examination after treatment. The two treatment failures in this group are of interest. One patient was re-treated with a single dose of 2 g. nitrimidazine and remains free of infection 2 months later. The other was likely to have been re-infected since it was subsequently discovered that her husband had failed to take his treatment. The incidence of side-effects (17 per cent.) in Groups D and E is double that reported for the standard course of nitrimidazine (Emanuel and de Carneri, 1969) , but none of the patients nor their partners suffered more than minor inconvenience. Many appreciated the uncomplicated course of treatment.
Studies carried out on rats and rabbits indicate that nitrimidazine does not interfere with embryofoetal organogenesis (Cantone and 10 others, 1969) , and toxic effects on adult humans have not been described. It therefore seems unreasonable to withold the drug from pregnant women after the first 10 weeks of pregnancy. 130 pregnant women were treated by Oliveira and Lima (1970) and no harmful effects were discovered. In the present series there were no adverse effects on the mother or the infant in 46 of the fifty pregnancies so far followed-up. The two stillbirths and one of the abortions reported here were not related to the use of nitrimidazine and the second abortion is most unlikely to have been.
Superinfection with Candida albicans was a probem as it is with any patients given effective treatment for trichomoniasis, but this is no more of a problem with oral nitrimidazine than it is with metronidazole.
Summary
Nitrimidazine combined with tetracycline and nystatin was administered vaginally to 111 women with Trichomonas vaginalis infection. Three different treatment schedules were used. The most effective was a course of eighteen pessaries (one each night) which gave a cure rate of 63 per cent. among the 51 followed.
Nitrimidazine was also given orally to 146 women. 88 were given a single dose of 2 g. 58 were treated with their sex partners, each receiving a single 2 g. 
